Diabetic foot
Not yet recruitingStudy on AUP1602-C for Treating Non-Healing Diabetic Foot Ulcers in Patients
- Disease:Diabetic foot
- Substances:Aup1602-C
Italy- Participants:18–64 years · 65+ years
- Substances:Aup1602-C
- Sponsor:Aurealis Oy
Rare diseases
Investigational molecules
Locations

Microkatu 1, 70210 Kuopio, Finland
Aurealis Oy focuses on clinical research in diabetic foot ulcer care, with attention to non-healing and neuro-ischaemic wounds that require advanced local treatment options.
The sponsor’s research activity is centred on topical approaches for patients with difficult-to-heal ulceration in the setting of diabetes mellitus.
Aurealis Oy runs clinical trials in conditions such as Diabetic foot, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Italy
GermanyIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.